CLINICAL_TRIALS
trial_result
· 2025-10-21
Clinical Trial Update: Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE [EARLY_Phase 1]
Summary
Raydiant Oximetry reports the completion of an early-phase 1 trial evaluating trans-abdominal fetal pulse oximetry (EFS-IDE). The study focuses on fetal hypoxia…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Raydiant Oximetry, Inc. | Conditions: Fetal Hypoxia, Fetal Distress | EARLY_Phase 1 | Status: COMPLETED